---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-006898"
form_type: "8-K"
ticker: "CSDX"
cik: "0001106861"
company_name: "CS DIAGNOSTICS CORP."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:07:55.122559+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CS Diagnostics files 8-K describing business and CS Protect Hydrogel product

## Summary
- Filing provides general overview of CS Diagnostics Corp. as a medical distribution company.
- Highlights CS Protect Hydrogel spacer gel for prostate cancer radiation therapy.
- No specific financial results, contracts, approvals, or material events reported.
- Lists company officers but no changes to leadership are disclosed.

## SEC filing metadata
- accession: 0001683168-24-006898
- form_type: 8-K
- ticker: CSDX
- cik: 0001106861
- company_name: CS DIAGNOSTICS CORP.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/0001683168-24-006898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/csdiag_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-006898
- JSON: https://secwatch.observer/filing/0001683168-24-006898.json
- Plain text: https://secwatch.observer/filing/0001683168-24-006898.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.